share_log

基蛋生物(603387.SH):控股子公司景川诊断在全国中小企业股份转让系统终止挂牌

Getein Biotech, Inc. (603387.SH): Its holding subsidiary Jingchuan Diagnostics has been delisted from the National Equities Exchange and Quotations system for small and medium-sized enterprises nationwide.

Gelonghui Finance ·  Oct 24 02:47

Getein Biotech,Inc (603387.SH) announced on October 24th that, according to the termination listing decision made by the National Equities Exchange and Quotations Co., Ltd., Jingchuan Diagnosis did not raise objections to the termination of listing matters to the National Equities Exchange and Quotations Co., Ltd. within the corresponding period, Jingchuan Diagnosis's stocks resumed trading and entered the delisting and reorganization period starting from October 10, 2024, which lasts for 10 trading days, with the final trading date being October 23, 2024. As of the disclosure date of this announcement, Jingchuan Diagnosis's delisting and reorganization period has ended, and Jingchuan Diagnosis's stocks were delisted on October 24, 2024.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment